nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—ESR2—urinary bladder cancer	0.559	0.619	CbGaD
Trilostane—ESR1—urinary bladder cancer	0.344	0.381	CbGaD
Trilostane—HSD3B1—female reproductive system—urinary bladder cancer	0.00562	0.171	CbGeAlD
Trilostane—HSD3B2—female reproductive system—urinary bladder cancer	0.00445	0.136	CbGeAlD
Trilostane—ESR2—prostate gland—urinary bladder cancer	0.00266	0.0812	CbGeAlD
Trilostane—HSD3B2—lymph node—urinary bladder cancer	0.0026	0.0795	CbGeAlD
Trilostane—ESR2—epithelium—urinary bladder cancer	0.00195	0.0597	CbGeAlD
Trilostane—ESR2—smooth muscle tissue—urinary bladder cancer	0.00188	0.0575	CbGeAlD
Trilostane—ESR1—prostate gland—urinary bladder cancer	0.00182	0.0556	CbGeAlD
Trilostane—ESR2—renal system—urinary bladder cancer	0.00181	0.0553	CbGeAlD
Trilostane—ESR2—female reproductive system—urinary bladder cancer	0.00145	0.0443	CbGeAlD
Trilostane—ESR1—epithelium—urinary bladder cancer	0.00134	0.0409	CbGeAlD
Trilostane—ESR2—vagina—urinary bladder cancer	0.00131	0.0401	CbGeAlD
Trilostane—ESR1—smooth muscle tissue—urinary bladder cancer	0.00129	0.0394	CbGeAlD
Trilostane—ESR1—renal system—urinary bladder cancer	0.00124	0.0379	CbGeAlD
Trilostane—ESR1—female reproductive system—urinary bladder cancer	0.000995	0.0304	CbGeAlD
Trilostane—ESR1—vagina—urinary bladder cancer	0.0009	0.0275	CbGeAlD
Trilostane—ESR2—lymph node—urinary bladder cancer	0.00085	0.0259	CbGeAlD
Trilostane—Danazol—ESR1—urinary bladder cancer	0.000613	0.32	CrCbGaD
Trilostane—Estradiol—ESR2—urinary bladder cancer	0.000608	0.318	CrCbGaD
Trilostane—ESR1—lymph node—urinary bladder cancer	0.000582	0.0178	CbGeAlD
Trilostane—Estradiol—ESR1—urinary bladder cancer	0.000374	0.196	CrCbGaD
Trilostane—HSD3B2—Metabolism—NAT1—urinary bladder cancer	0.000359	0.00578	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000353	0.00568	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—UGT2B7—urinary bladder cancer	0.000329	0.00528	CbGpPWpGaD
Trilostane—Progesterone—ESR1—urinary bladder cancer	0.000318	0.166	CrCbGaD
Trilostane—ESR1—FOXM1 transcription factor network—CDK4—urinary bladder cancer	0.000317	0.00509	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—PPARG—urinary bladder cancer	0.000312	0.00501	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—KRAS—urinary bladder cancer	0.000306	0.00493	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP4B1—urinary bladder cancer	0.000296	0.00476	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	0.00029	0.00466	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000288	0.00463	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TYMP—urinary bladder cancer	0.000287	0.00462	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—NCOR1—urinary bladder cancer	0.000287	0.00461	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SLC19A1—urinary bladder cancer	0.000279	0.00449	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—IGF1—urinary bladder cancer	0.000278	0.00448	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—CREBBP—urinary bladder cancer	0.000276	0.00445	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000276	0.00444	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—RB1—urinary bladder cancer	0.000275	0.00443	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PRSS3—urinary bladder cancer	0.000272	0.00438	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	0.000267	0.00429	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—CREBBP—urinary bladder cancer	0.000266	0.00428	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—urinary bladder cancer	0.000262	0.00421	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—HRAS—urinary bladder cancer	0.00026	0.00419	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NAT2—urinary bladder cancer	0.00026	0.00418	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000256	0.00412	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—PLAU—urinary bladder cancer	0.000255	0.00411	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—RHOA—urinary bladder cancer	0.000255	0.0041	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000254	0.00408	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.000246	0.00396	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000244	0.00393	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—CDKN2A—urinary bladder cancer	0.000242	0.00389	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CDK4—urinary bladder cancer	0.000241	0.00388	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—TERT—urinary bladder cancer	0.000241	0.00387	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.00024	0.00386	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.000237	0.00382	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	0.000232	0.00374	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—RRM2—urinary bladder cancer	0.000224	0.00361	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.000223	0.00358	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—RBX1—urinary bladder cancer	0.00022	0.00354	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000218	0.00351	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TYMP—urinary bladder cancer	0.000218	0.0035	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—ATM—urinary bladder cancer	0.000216	0.00348	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000212	0.00342	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.00021	0.00338	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—RB1—urinary bladder cancer	0.00021	0.00337	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000209	0.00336	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.000208	0.00335	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—HPGDS—urinary bladder cancer	0.000208	0.00334	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ENO2—urinary bladder cancer	0.000208	0.00334	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000206	0.00332	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—CCND1—urinary bladder cancer	0.000204	0.00329	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—MMP9—urinary bladder cancer	0.000202	0.00326	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GSTT1—urinary bladder cancer	0.000201	0.00324	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000198	0.00319	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NAT2—urinary bladder cancer	0.000197	0.00317	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000193	0.00311	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000192	0.00309	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000192	0.00309	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—EP300—urinary bladder cancer	0.000188	0.00303	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000188	0.00302	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.000187	0.00301	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000187	0.00301	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—SRC—urinary bladder cancer	0.000187	0.003	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000186	0.00299	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000184	0.00296	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—EP300—urinary bladder cancer	0.000181	0.00292	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000175	0.00281	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.00017	0.00274	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—RRM2—urinary bladder cancer	0.00017	0.00273	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NQO1—urinary bladder cancer	0.000167	0.00269	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CXCL8—urinary bladder cancer	0.000167	0.00269	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—MYC—urinary bladder cancer	0.000164	0.00264	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000163	0.00263	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000163	0.00262	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000162	0.00261	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000161	0.00259	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—MYC—urinary bladder cancer	0.000161	0.00259	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.000161	0.00259	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—S100B—urinary bladder cancer	0.00016	0.00257	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—HPGDS—urinary bladder cancer	0.000157	0.00253	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ENO2—urinary bladder cancer	0.000157	0.00253	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—RHOA—urinary bladder cancer	0.000157	0.00253	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000156	0.00252	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000156	0.00251	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CCND1—urinary bladder cancer	0.000156	0.00251	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000155	0.00249	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—KRAS—urinary bladder cancer	0.000155	0.00249	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GSTT1—urinary bladder cancer	0.000153	0.00245	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000153	0.00245	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000152	0.00245	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00015	0.00242	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000149	0.0024	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	0.000146	0.00235	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000146	0.00235	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—ERBB2—urinary bladder cancer	0.000146	0.00234	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NCOR1—urinary bladder cancer	0.000143	0.00231	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—EP300—urinary bladder cancer	0.000143	0.00231	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—IL2—urinary bladder cancer	0.000143	0.00229	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000142	0.00228	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000142	0.00228	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000141	0.00227	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GSTP1—urinary bladder cancer	0.00014	0.00224	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000139	0.00224	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—CCND1—urinary bladder cancer	0.000139	0.00224	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000137	0.0022	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000136	0.00219	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000135	0.00217	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	0.000134	0.00216	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000134	0.00215	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—TP53—urinary bladder cancer	0.000132	0.00213	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000132	0.00212	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—HRAS—urinary bladder cancer	0.000131	0.00211	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000131	0.00211	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000131	0.0021	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TYMS—urinary bladder cancer	0.00013	0.00209	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—CCND1—urinary bladder cancer	0.000129	0.00207	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GSTM1—urinary bladder cancer	0.000128	0.00206	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NCOR1—urinary bladder cancer	0.000128	0.00206	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NQO1—urinary bladder cancer	0.000127	0.00204	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000125	0.00201	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000123	0.00198	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000123	0.00198	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GPX1—urinary bladder cancer	0.000123	0.00198	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000121	0.00194	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000121	0.00194	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ERCC2—urinary bladder cancer	0.000121	0.00194	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.00012	0.00193	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000118	0.00189	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	0.000117	0.00188	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000117	0.00188	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000117	0.00188	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000117	0.00187	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—FGFR3—urinary bladder cancer	0.000116	0.00187	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—SRC—urinary bladder cancer	0.000115	0.00185	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000114	0.00184	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000114	0.00183	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—MTHFR—urinary bladder cancer	0.000113	0.00182	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—MYC—urinary bladder cancer	0.000112	0.00179	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000111	0.00179	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000111	0.00179	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—EGFR—urinary bladder cancer	0.000109	0.00175	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000109	0.00175	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000108	0.00174	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000107	0.00173	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000107	0.00172	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000106	0.00171	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GSTP1—urinary bladder cancer	0.000106	0.0017	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000102	0.00165	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	9.89e-05	0.00159	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	9.86e-05	0.00159	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TYMS—urinary bladder cancer	9.83e-05	0.00158	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GSTM1—urinary bladder cancer	9.72e-05	0.00156	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NCOR1—urinary bladder cancer	9.72e-05	0.00156	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	9.7e-05	0.00156	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	9.68e-05	0.00156	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	9.47e-05	0.00152	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	9.47e-05	0.00152	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	9.43e-05	0.00152	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GPX1—urinary bladder cancer	9.31e-05	0.0015	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—ESR1—urinary bladder cancer	9.25e-05	0.00149	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARG—urinary bladder cancer	9.19e-05	0.00148	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ERCC2—urinary bladder cancer	9.14e-05	0.00147	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	9.02e-05	0.00145	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TP53—urinary bladder cancer	8.95e-05	0.00144	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	8.95e-05	0.00144	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CREBBP—urinary bladder cancer	8.83e-05	0.00142	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MTHFR—urinary bladder cancer	8.59e-05	0.00138	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PPARG—urinary bladder cancer	8.44e-05	0.00136	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—SMC1A—urinary bladder cancer	8.42e-05	0.00135	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—ERBB2—urinary bladder cancer	8.27e-05	0.00133	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	8.23e-05	0.00132	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	8.13e-05	0.00131	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—CREBBP—urinary bladder cancer	8.11e-05	0.0013	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—HRAS—urinary bladder cancer	8.1e-05	0.0013	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	7.95e-05	0.00128	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—ESR2—urinary bladder cancer	7.69e-05	0.00124	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	7.35e-05	0.00118	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PTGS2—urinary bladder cancer	7.23e-05	0.00116	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	7.09e-05	0.00114	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—CDKN1A—urinary bladder cancer	7.07e-05	0.00114	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PTEN—urinary bladder cancer	7.05e-05	0.00113	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARG—urinary bladder cancer	6.97e-05	0.00112	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	6.89e-05	0.00111	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	6.76e-05	0.00109	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	6.74e-05	0.00108	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CREBBP—urinary bladder cancer	6.69e-05	0.00108	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PTEN—urinary bladder cancer	6.31e-05	0.00101	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	6.09e-05	0.000979	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—EP300—urinary bladder cancer	6.01e-05	0.000967	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	5.94e-05	0.000955	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	5.89e-05	0.000948	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	5.89e-05	0.000947	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	5.88e-05	0.000945	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	5.76e-05	0.000927	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—EGFR—urinary bladder cancer	5.73e-05	0.000922	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NCOR1—urinary bladder cancer	5.67e-05	0.000912	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	5.6e-05	0.000901	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PTGS2—urinary bladder cancer	5.48e-05	0.000881	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	5.45e-05	0.000876	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	5.45e-05	0.000876	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—KRAS—urinary bladder cancer	5.42e-05	0.000871	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ERCC2—urinary bladder cancer	5.33e-05	0.000857	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HDAC4—urinary bladder cancer	4.97e-05	0.000799	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.88e-05	0.000785	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	4.84e-05	0.000778	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—MYC—urinary bladder cancer	4.81e-05	0.000774	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PTEN—urinary bladder cancer	4.78e-05	0.000769	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.78e-05	0.000768	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—HRAS—urinary bladder cancer	4.6e-05	0.00074	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—EP300—urinary bladder cancer	4.56e-05	0.000733	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.55e-05	0.000732	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.51e-05	0.000726	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ESR1—urinary bladder cancer	4.45e-05	0.000716	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PPARG—urinary bladder cancer	4.25e-05	0.000684	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—SMC1A—urinary bladder cancer	4.25e-05	0.000683	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GLI1—urinary bladder cancer	4.16e-05	0.000669	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	4.09e-05	0.000657	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPARG—urinary bladder cancer	4.06e-05	0.000653	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.01e-05	0.000645	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—CREBBP—urinary bladder cancer	3.9e-05	0.000628	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—ESR2—urinary bladder cancer	3.7e-05	0.000595	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NCOR1—urinary bladder cancer	2.86e-05	0.00046	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RBX1—urinary bladder cancer	2.85e-05	0.000459	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—ERCC2—urinary bladder cancer	2.69e-05	0.000432	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TSC1—urinary bladder cancer	2.68e-05	0.000431	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—JAG1—urinary bladder cancer	2.55e-05	0.000411	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—MYC—urinary bladder cancer	2.43e-05	0.00039	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—MYC—urinary bladder cancer	2.32e-05	0.000372	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—S100B—urinary bladder cancer	2.07e-05	0.000332	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPARG—urinary bladder cancer	2.05e-05	0.000329	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—CREBBP—urinary bladder cancer	1.97e-05	0.000316	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	1.86e-05	0.000299	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TERT—urinary bladder cancer	1.64e-05	0.000263	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	1.5e-05	0.000242	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	1.28e-05	0.000206	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	1.26e-05	0.000203	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—MYC—urinary bladder cancer	1.17e-05	0.000188	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	1.16e-05	0.000186	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	1.07e-05	0.000172	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	1.02e-05	0.000163	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL2—urinary bladder cancer	9.71e-06	0.000156	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	9.47e-06	0.000152	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	9.19e-06	0.000148	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	9.16e-06	0.000147	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	9.14e-06	0.000147	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EP300—urinary bladder cancer	8.71e-06	0.00014	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SRC—urinary bladder cancer	8.47e-06	0.000136	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MYC—urinary bladder cancer	7.59e-06	0.000122	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	7.43e-06	0.000119	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	7.02e-06	0.000113	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TP53—urinary bladder cancer	6.24e-06	0.0001	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	5.96e-06	9.59e-05	CbGpPWpGaD
